Our data indicate that tumor variant LMP1 differentially regulates host B cell miR expression, suggesting viral genotype as an important consideration for the treatment of EBV+ B cell lymphomas. The gene discussed is PDLIM7; the disease is B-cell non-Hodgkin lymphoma.